A detailed history of National Bank Of Canada transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, National Bank Of Canada holds 7,100 shares of MIST stock, worth $13,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,100
Previous 7,100 -0.0%
Holding current value
$13,064
Previous $10,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.4 - $2.2 $4,550 - $7,150
3,250 Added 84.42%
7,100 $12,000
Q2 2023

Jul 26, 2023

BUY
$2.85 - $4.4 $10,687 - $16,500
3,750 Added 3750.0%
3,850 $10,000
Q4 2022

Jan 24, 2023

SELL
$3.53 - $9.5 $9,813 - $26,410
-2,780 Reduced 96.53%
100 $0
Q3 2022

Oct 13, 2022

SELL
$5.86 - $9.43 $70,097 - $112,801
-11,962 Reduced 80.6%
2,880 $26,000
Q1 2022

May 05, 2022

BUY
$4.1 - $8.24 $409 - $824
100 Added 0.68%
14,842 $94,000
Q4 2021

Jan 24, 2022

BUY
$5.47 - $7.13 $80,638 - $105,110
14,742 New
14,742 $96,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.2M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.